オルガノイドの世界市場：製品&サービス・オルガノイドタイプ・用途・エンドユーザー・地域別の予測 (～2032年)

オルガノイドの市場規模は、2023年の13億9,000万米ドル、2024年の16億8,000万米ドルから、予測期間中は23.55%のCAGRで推移し、2032年には91億6,000万米ドルの規模に成長すると予測されています。同市場は、個別化医療に対する需要の高まりと、創薬および毒性学研究の応用の増加により成長を遂げています。

オルガノイドの市場は、個別化医療に対する需要の増加によって牽引されています。個別化医療とも呼ばれる精密医療は、患者一人ひとりの特徴に合わせて治療をカスタマイズすることを特徴とします。この方法は、遺伝子構成、環境、ライフスタイルなどの要因を考慮することで、より効果的で的を絞った治療を提供するように設計されています。オルガノイドは、臓器の機能性と複雑さを再現したミニチュアの3次元組織構造体であるため、個別化医療の進歩において重要な道具です。

治療に対する個人の反応に大きなばらつきがあることを認めることは、個別化医療の重要な要素です。動物モデルや2次元細胞培養は従来の医薬品開発で頻繁に採用されていますが、ヒトのバイオロジーを正確には反映していません。オルガノイドは、疾患メカニズムの研究や薬物反応の評価に、より生理学的に適切なプラットフォームを提供します。研究者は、患者由来のオルガノイドを利用することで、疾患の特徴的な特性をより包括的に理解し、さまざまな治療に対する個人の反応を予測することができます。

地域別展望

北米地域が2023年に最大の市場シェアを占め、予測期間中は22.88%のCAGRで推移し、2032年には34億2,000万米ドルの規模に増加すると予測されています。

技術の進歩により、3Dオルガノイドやスフェロイドの開発が容易になり、米国やカナダのバイオテクノロジー分野でオルガノイドベースの研究モデルの利用が増加しています。米国の主要な学術研究機関やバイオテクノロジー企業は、現在進行中のオルガノイド技術の進歩の先陣を切ってきました。

欧州は、北米に次いで第2位の市場シェアを示しています。欧州のライフサイエンスへの多額の投資と強固な研究インフラが大きな要因です。オルガノイド研究の最前線にある有名な研究機関やバイオテクノロジー企業は、英国、ドイツ、オランダなどの国にあります。

アジア太平洋地域は大幅な成長を遂げています。これはさまざまな注目すべき要因によって促進されています。オルガノイドは、幹細胞や組織に由来する3次元の小型臓器であり、再生医療応用、創薬、疾患モデリングに使用される可能性を秘めています。

当レポートでは、世界のオルガノイドの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 促進要因
  • 個別化医療の需要の高まり
  • 創薬と毒性研究における用途の拡大
• 抑制要因
  • 市場の成長に影響を与える規制上の課題
  • 開発・保守コストの高さ
• 機会
  • オルガノイドの製造と応用を強化する技術の進歩
• 傾向
  • 再生医療への投資の増加
  • 発生生物学の研究における利用の拡大
• 課題
  • オルガノイドの調達と実験をめぐる倫理的懸念
  • 既存の医療行為や技術との統合の課題
• COVID-19の影響分析

第5章 市場要因分析

• バリューチェーン分析
• ポーターのファイブフォース分析

第6章 世界のオルガノイド市場：製品&サービス別

• 概要
• 製品
• サービス

第7章 世界のオルガノイド市場：オルガノイドタイプ別

• 概要
• 肝臓
• 腎臓
• 膵臓
• 腸
• 心臓
• その他

第8章 世界のオルガノイド市場：用途別

• 概要
• 薬物検査
• 発生生物学
• 個別化医療
• 再生医療
• その他

第9章 世界のオルガノイド市場：エンドユーザー別

• 概要
• 学術・研究機関
• 製薬・バイオ企業
• CRO
• その他

第10章 世界のオルガノイド市場：地域別

• 世界
• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 競合情勢

• 競争概要
• 世界のオルガノイド市場の主要企業
• 競合ベンチマーキング
• 主な展開と成長戦略

第12章 企業プロファイル

• HUB ORGANOIDS
• NEYROBLASTGX
• STEMCELL TECHNOLOGIES
• BIO-TECHNE
• THERMO FISHER SCIENTIFIC INC
• 3DNAMICS INC.
• MOLECULAR DEVICES, LLC
• MERCK KGGA
• CORNING INCORPORATED
• CN BIO INNOVATIONS LTD

第13章 データの引用

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 3 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 4 GLOBAL ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 5 GLOBAL ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 6 GLOBAL ORGANOIDS MARKET, BY REGION, 2020-2032 (USD MILLION)
• TABLE 7 NORTH AMERICA: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 8 NORTH AMERICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 9 NORTH AMERICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 10 NORTH AMERICA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 11 NORTH AMERICA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 12 US ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 13 US ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 14 US ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 15 US ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 16 CANADA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 17 CANADA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 18 CANADA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 19 CANADA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 20 MEXICO ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 21 MEXICO ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 22 MEXICO ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 23 MEXICO ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 24 EUROPE: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 25 EUROPE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 26 EUROPE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 27 EUROPE ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 28 EUROPE ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 29 GERMANY ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 30 GERMANY ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 31 GERMANY ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 32 GERMANY ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 33 FRANCE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 34 FRANCE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 35 FRANCE ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 36 FRANCE ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 37 UK ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 38 UK ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 39 UK ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 40 UK ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 41 SPAIN ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 42 SPAIN ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 43 SPAIN ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 44 SPAIN ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 45 ITALY ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 46 ITALY ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 47 ITALY ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 48 ITALY ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 49 REST OF EUROPE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 50 REST OF EUROPE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 51 REST OF EUROPE ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 52 REST OF EUROPE ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 53 ASIA PACIFIC: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 54 ASIA PACIFIC ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 55 ASIA PACIFIC ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 56 ASIA PACIFIC ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 57 ASIA PACIFIC ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 58 CHINA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 59 CHINA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 60 CHINA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 61 CHINA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 62 INDIA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 63 INDIA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 64 INDIA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 65 INDIA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 66 JAPAN ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 67 JAPAN ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 68 JAPAN ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 69 JAPAN ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 70 SOUTH KOREA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 71 SOUTH KOREA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 72 SOUTH KOREA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 73 SOUTH KOREA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 74 AUSTRALIA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 75 AUSTRALIA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 76 AUSTRALIA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 77 AUSTRALIA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 78 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 79 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 80 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 81 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 82 REST OF THE WORLD: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 83 REST OF THE WORLD ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 84 REST OF THE WORLD ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 85 REST OF THE WORLD ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 86 REST OF THE WORLD ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 87 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 88 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 89 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 90 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 91 SOUTH AMERICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 92 SOUTH AMERICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 93 SOUTH AMERICA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 94 SOUTH AMERICA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 95 MAJOR PLAYERS IN THE GLOBAL ORGANOIDS MARKET
• TABLE 96 PRODUCT LAUNCH/DEVELOPMENT
• TABLE 97 CONTRACT & AGREEMENT
• TABLE 98 HUB ORGANOIDS: PRODUCTS/SERVICES OFFERED
• TABLE 99 NEYROBLASTGX: PRODUCTS OFFERED
• TABLE 100 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 101 STEMCELL TECHNOLOGIES: KEY DEVELOPMENTS
• TABLE 102 BIO-TECHNE: PRODUCTS OFFERED
• TABLE 103 BIO-TECHNE: KEY DEVELOPMENTS
• TABLE 104 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
• TABLE 105 3DNAMICS INC.: PRODUCTS OFFERED
• TABLE 106 MOLECULAR DEVICES, LLC: PRODUCTS/SERVICES OFFERED
• TABLE 107 MOLECULAR DEVICES, LLC: KEY DEVELOPMENTS
• TABLE 108 MERCK KGGA: PRODUCTS OFFERED
• TABLE 109 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 110 CN BIO INNOVATIONS LTD: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL ORGANOIDS MARKET: EXECUTIVE SUMMARY
• FIGURE 2 GLOBAL ORGANOIDS MARKET: STRUCTURE
• FIGURE 3 GLOBAL ORGANOIDS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
• FIGURE 4 VALUE CHAIN ANALYSIS OF THE GLOBAL ORGANOIDS MARKET
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ORGANOIDS MARKET
• FIGURE 6 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2023 & 2032(USD MILLION)
• FIGURE 7 GLOBAL ORGANOIDS MARKET SHARE (%), BY PRODUCT & SERVICE,
• FIGURE 8 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2023 & 2032(USD MILLION)
• FIGURE 9 GLOBAL ORGANOIDS MARKET SHARE (%), BY TYPE OF ORGANOIDS,
• FIGURE 10 GLOBAL ORGANOIDS MARKET, BY APPLICATION, 2023 & 2032(USD MILLION)
• FIGURE 11 GLOBAL ORGANOIDS MARKET SHARE (%), BY APPLICATION,
• FIGURE 12 GLOBAL ORGANOIDS MARKET, BY END-USERS, 2023 & 2032(USD MILLION)
• FIGURE 13 GLOBAL ORGANOIDS MARKET SHARE (%), BY END-USERS,
• FIGURE 14 GLOBAL ORGANOIDS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
• FIGURE 15 GLOBAL ORGANOIDS MARKET SHARE, BY REGION, 2023 (% SHARE)
• FIGURE 16 NORTH AMERICA: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 17 NORTH AMERICA: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 18 EUROPE: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 19 EUROPE: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 20 ASIA PACIFIC: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 21 ASIA PACIFIC: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 22 REST OF THE WORLD: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 23 REST OF THE WORLD: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 24 BENCHMARKING OF MAJOR COMPETITORS
• FIGURE 25 HUB ORGANOIDS: SWOT ANALYSIS
• FIGURE 26 NEYROBLASTGX: SWOT ANALYSIS
• FIGURE 27 STEMCELL TECHNOLOGIES: SWOT ANALYSIS
• FIGURE 28 BIO-TECHNE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 29 BIO-TECHNE: SWOT ANALYSIS
• FIGURE 30 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 31 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
• FIGURE 32 3DNAMICS INC.: SWOT ANALYSIS
• FIGURE 33 MOLECULAR DEVICES, LLC: SWOT ANALYSIS
• FIGURE 34 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 35 MERCK KGGA: SWOT ANALYSIS
• FIGURE 36 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 37 CORNING INCORPORATED: SWOT ANALYSIS
• FIGURE 38 CN BIO INNOVATIONS LTD: SWOT ANALYSIS

Global Organoids Market Research Report Information By Product and Service (Product and Service), By Type of Organoids (Liver, Kidney, Pancreas, Intestine, Heart, and others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others), By End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Company, Contract Research Organizations (CROs), and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) -Forecast Till 2032

Market Overview

In 2023, the Organoids Market was estimated to be worth USD 1.39 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 23.55% from USD 1.68 billion in 2024 to USD 9.16 billion by 2032 during the forecast period (2024-2032). The market is experiencing growth due to the increasing demand for personalized medicine and the increasing application of drug discovery and toxicology studies.

The Organoids Market is being driven by the increasing demand for personalized medicine. Precision medicine, which is also referred to as personalized medicine, is characterized by the customization of medical treatment to the unique characteristics of each patient. This method is designed to deliver more effective and targeted therapies by taking into account factors such as genetic composition, environment, and lifestyle. Organoids are a critical instrument in the advancement of personalized medicine, as they are miniature 3D tissue structures that replicate the functionality and complexity of organs.

The acknowledgment of the significant variability in the way individuals respond to treatments is a critical component of personalized medicine. Animal models or 2D cell cultures are frequently employed in conventional drug development methods, but they do not accurately reflect human biology. Organoids provide a more physiologically relevant platform for the investigation of disease mechanisms and the assessment of drug responses. Researchers can gain a more comprehensive understanding of the distinctive characteristics of diseases and predict the responses of individuals to various treatments by utilizing patient-derived organoids.

Market segment insights

The Organoids Market has been segmented into product and service based on product and service.

The Organoids Market has been segmented into the following categories: Liver, Kidney, Pancreas, Intestine, Heart, and Others according to the variety of organoids.

The Market has been segmented into Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others, as determined by its application.

The Market has been segmented into Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and others based on End-Users.

Regional Perspectives

The Organoids Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World based on region. In 2023, North America held the largest market share, which is expected to increase to USD 3.42 billion by 2032, representing a compound annual growth rate (CAGR) of 22.88% during the forecast period.

Advancements in technology have facilitated the development of 3D organoids and spheroids, which have contributed to the rise in the use of organoid-based research models in the biotechnology sector of the United States and Canada. Major academic research institutions and biotechnology companies in the United States have been at the vanguard of the ongoing advancement of organoid technology.

Europe is the second-largest organoid market share, following the Americas region. Europe's substantial investment in life sciences and robust research infrastructure are significant factors. Renowned research institutions and biotechnology corporations that are at the forefront of organoid research are located in countries such as the United Kingdom, Germany, and the Netherlands.

The organoids market in the Asia Pacific region is experiencing substantial growth, which is being promoted by a variety of notable factors. Organoids, miniaturized organs that are three-dimensional and are derived from stem cells or tissue, have the potential to be used in regenerative medicine applications, drug discovery, and disease modeling.

Major Players

Merck KGgA, Corning Incorporated, STEMCELL Technologies, Bio-Techne, Molecular Devices, LLC, and Thermo Fisher Scientific Inc. are among the major participants in the Organoids Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research DATA FLOW:
  • 3.5.2 Primary Research: Number of Interviews conducted
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Type
• 3.8 DATA MODELING
  • 3.8.1 microeconomic factor analysis:
  • 3.8.2 Data modeling:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Rising demand for personalized medicine
  • 4.2.2 Growing applications in drug discovery and toxicology studies
• 4.3 RESTRAINTS
  • 4.3.1 Regulatory challenges impacting market growth
  • 4.3.2 High cost of development and maintenance
• 4.4 OPPORTUNITY
  • 4.4.1 Technological advancements enhancing organoid production and applications
• 4.5 TREND
  • 4.5.1 Rising investment in regenerative medicine
  • 4.5.2 Expanding use in studying developmental biology
• 4.6 CHALLENGES
  • 4.6.1 Ethical concerns surrounding organoid sourcing and experimentation
  • 4.6.2 Integration challenges with existing medical practices and technologies
• 4.7 IMPACT ANALYSIS OF COVID-19
  • 4.7.1 Impact on R & D
  • 4.7.2 Impact on Supply Chain
  • 4.7.3 Impact on Pricing

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 Raw Material Sourcing and Research & Development (R&D)
  • 5.1.2 Organoid Production and Quality Control/Assurance
  • 5.1.3 Distribution and Logistics
  • 5.1.4 Application in Research, Drug Discovery, and Clinical Translation
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 Threat of New Entrants
  • 5.2.2 Bargaining Power of Suppliers
  • 5.2.3 Threat of Substitutes
  • 5.2.4 Bargaining Power of Buyers
  • 5.2.5 Intensity of Rivalry

6 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE

• 6.1 OVERVIEW

7 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS

• 7.1 OVERVIEW

8 GLOBAL ORGANOIDS MARKET, BY APPLICATION

• 8.1 OVERVIEW

9 GLOBAL ORGANOIDS MARKET, BY END-USERS

• 9.1 OVERVIEW

10 GLOBAL ORGANOIDS MARKET, BY REGION

• 10.1 GLOBAL
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 EUROPE
  • 10.3.1 germany
  • 10.3.2 France
  • 10.3.3 UK
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 ASIA PACIFIC
  • 10.4.1 china
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 South Korea
  • 10.4.5 Australia
  • 10.4.6 Rest of Asia Pacific
• 10.5 REST OF THE WORLD
  • 10.5.1 Middle East & Africa
  • 10.5.2 South America

11 COMPETITIVE LANDSCAPE

• 11.1 COMPETITIVE OVERVIEW
• 11.2 MAJOR PLAYERS IN THE GLOBAL ORGANOIDS MARKET
• 11.3 COMPETITIVE BENCHMARKING
• 11.4 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 11.4.1 Product launch/development
  • 11.4.2 Contract & Agreement

12 COMPANY PROFILES

• 12.1 HUB ORGANOIDS
  • 12.1.1 Company Overview
  • 12.1.2 FINANCIAL OVERVIEW
  • 12.1.3 Products/Services Offered
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Strategies
• 12.2 NEYROBLASTGX
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 PRODUCTS OFFERED
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 SWOT ANALYSIS
  • 12.2.6 KEY STRATEGIES
• 12.3 STEMCELL TECHNOLOGIES
  • 12.3.1 COMPANY OVERVIEW
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCTS OFFERED
  • 12.3.4 KEY DEVELOPMENTS
  • 12.3.5 SWOT ANALYSIS
  • 12.3.6 KEY STRATEGIES
• 12.4 BIO-TECHNE
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 Financial Overview
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 Key Developments
  • 12.4.5 SWOT ANALYSIS
  • 12.4.6 KEY STRATEGIES
• 12.5 THERMO FISHER SCIENTIFIC INC
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 Financial Overview
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 SWOT ANALYSIS
  • 12.5.6 KEY STRATEGIES
• 12.6 3DNAMICS INC.
  • 12.6.1 COMPANY OVERVIEW
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 SWOT ANALYSIS
  • 12.6.6 KEY STRATEGIES
• 12.7 MOLECULAR DEVICES, LLC
  • 12.7.1 Company Overview
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 Products/Services Offered
  • 12.7.4 Key Developments
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Strategies
• 12.8 MERCK KGGA
  • 12.8.1 COMPANY OVERVIEW
  • 12.8.2 Financial Overview
  • 12.8.3 PRODUCTS OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 SWOT ANALYSIS
  • 12.8.6 KEY STRATEGIES
• 12.9 CORNING INCORPORATED
  • 12.9.1 COMPANY OVERVIEW
  • 12.9.2 Financial Overview
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 SWOT ANALYSIS
  • 12.9.6 KEY STRATEGIES
• 12.10 CN BIO INNOVATIONS LTD
  • 12.10.1 COMPANY OVERVIEW
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 SWOT ANALYSIS
  • 12.10.6 KEY STRATEGIES

13 DATA CITATIONS